Vanguard Capital Wealth Advisors Has $6.89 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Vanguard Capital Wealth Advisors raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,923 shares of the healthcare conglomerate’s stock after buying an additional 201 shares during the period. UnitedHealth Group comprises 4.8% of Vanguard Capital Wealth Advisors’ holdings, making the stock its 4th biggest holding. Vanguard Capital Wealth Advisors’ holdings in UnitedHealth Group were worth $6,888,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also modified their holdings of UNH. Vanguard Group Inc. grew its holdings in UnitedHealth Group by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 83,860,515 shares of the healthcare conglomerate’s stock worth $44,150,045,000 after acquiring an additional 250,291 shares in the last quarter. Wellington Management Group LLP increased its holdings in UnitedHealth Group by 2.1% during the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock valued at $12,715,790,000 after buying an additional 527,526 shares during the period. Capital Research Global Investors lifted its holdings in UnitedHealth Group by 2.2% during the fourth quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock worth $7,961,369,000 after buying an additional 324,733 shares during the period. Capital International Investors increased its holdings in shares of UnitedHealth Group by 4.8% in the 4th quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after acquiring an additional 542,424 shares during the period. Finally, Norges Bank bought a new stake in UnitedHealth Group during the fourth quarter valued at about $5,802,231,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH traded up $9.11 during mid-day trading on Friday, reaching $495.55. The company had a trading volume of 1,390,712 shares, compared to its average volume of 4,127,289. The stock has a 50 day moving average of $498.30 and a two-hundred day moving average of $502.61. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $456.10 billion, a P/E ratio of 29.74, a PEG ratio of 1.40 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the firm earned $6.26 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.70%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is currently 51.34%.

Analysts Set New Price Targets

UNH has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. raised their price target on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Truist Financial reaffirmed a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 17th. Bank of America reissued a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Wells Fargo & Company decreased their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Finally, StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, June 20th. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.